1. 101PInvolvement of miR-99a in resistance to chemotherapy in triple-negative breast cancer. (16th September 2018) Authors: Garrido-Cano, I; Pattanayak, B; Adam-Artigues, A; Cabello, P; Pineda, B; Tormo, E; Albanell, J; Rojo, F; Lluch, A; Eroles, P Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1833PDLack of efficiency of precision oncology with target-based investigational treatments for patients in early phase clinical trials based on pre-screened molecular alterations. (23rd October 2018) Authors: Doger de Spéville, B; Moreno, V; Hernandez, T; Boni, V; de Miguel, M J; Rojo, F; Lopez-Rios, F; Calvo, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 486PProspective biomarker study in advanced RAS wild-type colorectal cancer: POSIBA trial. (23rd October 2018) Authors: García Albéniz, X; Alonso, V; Escudero, P; Méndez, M; Gallego Plazas, J; Rodriguez, J R; Salud Salvia, A; Fernández-Plana, J; Manzano Alemany, H; Zanui, M; Falcó, E; Feliu Batlle, J; Gil-Raga, M; Fernández-Martos, C; Bohn Sarmiento, U; Alonso López, M C; Calderero Aragón, V; Rojo, F; Cuatrecasas,... Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 545PClinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. (23rd October 2018) Authors: Montagut, C; Alonso, V; Escudero, P; Fernández-Martos, C; Salud Salvia, A; Méndez, M; Gallego Plazas, J; Rodriguez, J R; Martín-Richard, M; Fernández-Plana, J; Aparicio, J; Feliu Batlle, J; García de Albéniz, X; Rojo, F; Fernández, V; Claes, B; Maertens, G G; Sablon, E; Jacobs, B A W; Maurel, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 73PRole of miR-449 family on doxorubicin-based chemotherapy response in triple-negative breast cancer. (16th September 2018) Authors: Tormo Martin, E; Adam-Artigues, A; Garrido-Cano, I; Pineda Merlo, B; Pattanayak, B; Cabello, P; Albanell, J; Rojo, F; Lluch, A; Eroles, P Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 80PSET overexpression promotes colorectal cancer progression and determines poor outcome in patients with localized disease. (23rd October 2018) Authors: Torrejón, B; Pedregal Trujillo, M; Santos, A; Rubio, J; Luque, M; Sanz, M; Carames, C; Zazo, S; Madoz-Gurpide, J; Rojo, F; Garcia Foncillas, J; Ion, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Increased tumour necrosis factor α production in mesenteric lymph nodes of cirrhotic patients with ascites. Issue 7 (1st July 2003) Authors: Genescà, J; Martí, R; Rojo, F; Campos, F; Peribáñez, V; Gónzalez, A; Castells, L; Ruiz-Marcellán, C; Margarit, C; Esteban, R; Guardia, J; Segura, R Journal: Gut Issue: Volume 52:Issue 7(2003) Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗